0001209191-17-046031.txt : 20170721
0001209191-17-046031.hdr.sgml : 20170721
20170721201039
ACCESSION NUMBER: 0001209191-17-046031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170719
FILED AS OF DATE: 20170721
DATE AS OF CHANGE: 20170721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 17977418
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-19
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2017-07-19
4
M
0
6445
77.31
A
26516
D
Common Stock
2017-07-19
4
M
0
4500
48.74
A
31016
D
Common Stock
2017-07-19
4
M
0
8438
45.11
A
39454
D
Common Stock
2017-07-19
4
M
0
3437
83.36
A
42891
D
Common Stock
2017-07-19
4
M
0
3437
96.87
A
46328
D
Common Stock
2017-07-19
4
M
0
3867
109.14
A
50195
D
Common Stock
2017-07-19
4
M
0
6445
91.05
A
56640
D
Common Stock
2017-07-19
4
M
0
3437
90.29
A
60077
D
Common Stock
2017-07-19
4
S
0
40006
161.00
D
20071
D
Common Stock
2017-07-21
4
S
0
2937
161.91
D
17134
D
Common Stock
2017-07-21
4
S
0
500
161.92
D
16634
D
Common Stock
169
I
401k
Stock Option (Right to Buy)
77.31
2017-07-19
4
M
0
6445
0.00
D
2024-02-04
Common Stock
6445
3867
D
Stock Option (Right to Buy)
48.74
2017-07-19
4
M
0
4500
0.00
D
2022-07-24
Common Stock
4500
0
D
Stock Option (Right to Buy)
45.11
2017-07-19
4
M
0
8438
0.00
D
2023-02-04
Common Stock
8438
0
D
Stock Option (Right to Buy)
83.36
2017-07-19
4
M
0
3437
0.00
D
2023-07-29
Common Stock
3437
860
D
Stock Option (Right to Buy)
96.87
2017-07-19
4
M
0
3437
0.00
D
2024-07-14
Common Stock
3437
10313
D
Stock Option (Right to Buy)
109.14
2017-07-19
4
M
0
3867
0.00
D
2025-02-02
Common Stock
3867
16758
D
Stock Option (Right to Buy)
91.05
2017-07-19
4
M
0
6445
0.00
D
2026-02-01
Common Stock
6445
14180
D
Stock Option (Right to Buy)
90.29
2017-07-19
4
M
0
3437
0.00
D
2026-07-11
Common Stock
3437
10313
D
Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 2/5/2014.
Fully vested.
The option vests in 16 quarterly installments from 7/30/2013.
The option vests in 16 quarterly installments from 7/15/2014.
The option vests in 16 quarterly installments from 2/3/2015.
The option vests in 16 quarterly installments from 2/2/2016.
The option vests in 16 quarterly installments from 7/12/2016.
/s/ Omar White, Attorney-in-Fact
2017-07-21